Trends in the prevalence of chronic kidney disease in Korean adults: The Korean National Health and Nutrition Examination Survey from 1998 to 2009

Nephrology Dialysis Transplantation

Volumn 28, Issue 4, 2013, Pages 927-936

  Kang, Hee Taik ^a,b   Lee, Jungeun ^c   Linton, John A ^c   Park, Byoung Jin ^d   Lee, Yong Jae ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d CHA University   (South Korea)

Author keywords

chronic kidney disease; glomerular filtration rate; prevalence; proteinuria

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; BODY MASS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH SURVEY; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL ASSESSMENT; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; PUBLIC HEALTH; REVIEW; RISK FACTOR; SEX DIFFERENCE; TREND STUDY; URINALYSIS;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; REPUBLIC OF KOREA; RISK FACTORS; YOUNG ADULT;

EID: 84876004110     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs535     Document Type: Review

References (34)

1. Sarnak MJ. Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 2003; 41: 11-17
2. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 2004; 351: 1296-1305
3. Keith DS, Nichols GA, Gullion CM et al. Longitudinal followup and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663 (Pubitemid 38392981)
4. Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259 (Pubitemid 47172384)
5. Madan P, Kalra OP, Agarwal S et al. Cognitive impairment in chronic kidney disease. Nephrol Dial Transplant 2007; 22: 440-444 (Pubitemid 46189887)
6. Nagata M, Ninomiya T, Doi Y et al. Trends in the prevalence of chronic kidney disease and its risk factors in a general Japanese population: the Hisayama Study. Nephrol Dial Transplant 2010; 25: 2557-2564
7. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047 (Pubitemid 350074801)
8. Imai E, Horio M, Watanabe T et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009; 13: 621-630
9. Zhang L, Zhang P, Wang F et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 2008; 51: 373-384 (Pubitemid 351273470)
10. Lee SW, Kim YC, Oh SW et al. Trends in the prevalence of chronic kidney disease, other chronic diseases and health-related behaviors in an adult Korean population: data from the Korean National Health and Nutrition Examination Survey (KNHANES). Nephrol Dial Transplant 2011; 26: 3975-3980
11. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999; 130: 461-470 (Pubitemid 29135798)
12. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089-2100 (Pubitemid 41623371)
13. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-S266
14. International Obesity Task Force & World Health Organization. The Asian-Pacific perspective: Redefining obesity and its treatment 2000 http://www.wpro.who.int/nutrition/documents/Redefining-obesity/en/index.html. (August 2012, date last accessed)
15. O'Seaghdha CM, Perkovic V, Lam TH et al. Blood pressure is a major risk factor for renal death: an analysis of 560 352 participants from the Asia-Pacific region. Hypertension 2009; 54: 509-515
16. Yamagata K, Ishida K, Sairenchi T et al. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int 2007; 71: 159-166 (Pubitemid 46094690)
17. Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet 2001; 357: 1601-1608 (Pubitemid 32488830)
18. Yano Y, Fujimoto S, Sato Y et al. Association between prehypertension and chronic kidney disease in the Japanese general population. Kidney Int 2012; 81: 293-299
19. Iseki K, Oshiro S, Tozawa M et al. Prevalence and correlates of diabetes mellitus in a screened cohort in Okinawa, Japan. Hypertens Res 2002; 25: 185-190 (Pubitemid 34464447)
20. Hou X, Song J, Li XN et al. Metformin reduces intracellular reactive oxygen species levels by upregulating expression of the antioxidant thioredoxin via the AMPK-FOXO3 pathway. Biochem Biophys Res Commun 2010; 396: 199-205
21. Fidan E, Onder Ersoz H, Yilmaz M et al. The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol 2011; 48: 297-302
22. Hung AM, Roumie CL, Greevy RA et al. Comparative effectiveness of incident oral antidiabetic drugs on kidney function. Kidney Int 2012; 81: 698-706
23. Muntner P, Coresh J, Smith JC et al. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 2000; 58: 293-301 (Pubitemid 30429874)
24. Schaeffner ES, Kurth T, Curhan GC et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 2003; 14: 2084-2091 (Pubitemid 36909916)
25. Tozawa M, Iseki K, Iseki C et al. Triglyceride, but not total cholesterol or low-density lipoprotein cholesterol levels, predict development of proteinuria. Kidney Int 2002; 62: 1743-1749 (Pubitemid 35286282)
26. Zoppini G, Targher G, Chonchol M et al. Higher HDL cholesterol levels are associated with a lower incidence of chronic kidney disease in patients with type 2 diabetes. Nutr Metab Cardiovasc Dis 2009; 19: 580-586
27. Epstein M, Campese VM. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function. Am J Kidney Dis 2005; 45: 2-14 (Pubitemid 40038040)
28. Lauretani F, Maggio M, Pizzarelli F et al. Omega-3 and renal function in older adults. Curr Pharm Des 2009; 15: 4149-4156
29. Sandhu S, Wiebe N, Fried LF et al. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol 2006; 17: 2006-2016 (Pubitemid 44036185)
30. Ross R, Janssen I, Dawson J et al. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obes Res 2004; 12: 789-798 (Pubitemid 41127314)
31. Seip RL, Semenkovich CF. Skeletal muscle lipoprotein lipase: molecular regulation and physiological effects in relation to exercise. Exerc Sport Sci Rev 1998; 26: 191-218 (Pubitemid 128461557)
32. Gupta AK, Ross EA, Myers JN et al. Increased reverse cholesterol transport in athletes. Metabolism 1993; 42: 684-690 (Pubitemid 23173405)
33. Seip RL, Moulin P, Cocke T et al. Exercise training decreases plasma cholesteryl ester transfer protein. Arterioscler Thromb 1993; 13: 1359-1367 (Pubitemid 23271139)
34. White SL, Polkinghorne KR, Cass A et al. Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant 2009; 24: 2464-2472